(Q41720833)

8 October 2017

title

Restoring Sinus Rhythm in Patients With Atrial Flutter and Fibrillation: Pharmacologic or Electrical Cardioversion? (English)

1 reference

8 October 2017

1 reference

Gallik D

1

1 reference

8 October 2017

Altamirano J

series ordinal

2

1 reference

8 October 2017

Singh BN

series ordinal

3

1 reference

8 October 2017

publication date

1 April 1997

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

8 October 2017

published in

1 reference

8 October 2017

volume

2

1 reference

8 October 2017

issue

2

1 reference

8 October 2017

page(s)

135-144

1 reference

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Atrial fibrillation and flutter: maintaining stability of sinus rhythm versus ventricular rate control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Canadian atrial fibrillation anticoaguiation (CAFA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Echographic assessment of atrial transport, mitral movement, and ventricular performance following electroversion of supraventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Left atrial function after electrical conversion to sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

A COMPUTER MODEL OF ATRIAL FIBRILLATION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Quinidine in maintenance of sinus rhythm after electroconversion of chronic atrial fibrillation. A controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Value of quinidine in maintenance of sinus rhythm after electric conversion of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Disopyramide in the maintenance of sinus rhythm after electroconversion of atrial fibrillation. A placebo-controlled one-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Maintenance of sinus rhythm after atrial defibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Flecainide acetate in the prevention of paroxysmal atrial fibrillation: a nine-month follow-up of more than 500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

The coming of age of the class III antiarrhythmic principle: retrospective and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Left ventricular hypertrophy in hypertensive patients is associated with abnormal rate adaptation of QT interval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Proarrhythmia with class III antiarrhythmic drugs: definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

New approaches to treatment of atrial flutter and tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424849700200207

10.1177/107424849700200207

21 January 2018

Identifiers

DOI

1 reference

8 October 2017

1 reference